Expertise in
43
conditions

Dr. Robert M. Pascuzzi

Neurology
Indiana University Psychiatric Associates Inc.
355 W 16th St, 
Indianapolis, IN 
Accepting New Patients
Offers Telehealth
47 Years of Experience
Expertise in
43
conditions
Indiana University Psychiatric Associates Inc.
355 W 16th St, 
Indianapolis, IN 

Overview

Robert Pascuzzi is a Neurologist practicing medicine in Indianapolis, Indiana. He has been practicing medicine for over 47 years.

Dr. Pascuzzi is highly rated in 43 conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Lambert-Eaton Syndrome, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal and Bulbar Muscular Atrophy, and Thymectomy.

He is actively involved in clinical research, co-authoring 30 peer reviewed articles and participating in 5 clinical trials. Dr. Pascuzzi is currently accepting new patients.

Graduate Year

1979

Specialties

Neurology

Licenses

Psychiatry & Neurology in IN

Hospital Affiliations

Indiana University Health
Eskenazi Health
Indiana University Health North Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 13 Less Insurance Carriers -

Locations

Indiana University Psychiatric Associates Inc.
355 W 16th St, Indianapolis, IN 46202

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 2b/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 12 Month Clinical Trial to Evaluate the Efficacy and Safety of MN-166 (Ibudilast) Followed by Open-Label Extension Phase in Subjects With Amyotrophic Lateral Sclerosis
A Phase 2b/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 12 Month Clinical Trial to Evaluate the Efficacy and Safety of MN-166 (Ibudilast) Followed by Open-Label Extension Phase in Subjects With Amyotrophic Lateral Sclerosis
Enrollment Status: Active_not_recruiting
Publish Date: March 06, 2026
Intervention Type: Drug
Study Drug: MN-166
Study Phase: Phase 2/Phase 3
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
Enrollment Status: Completed
Publish Date: December 12, 2024
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of lGIV-C as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of lGIV-C as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
Enrollment Status: Completed
Publish Date: March 30, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in Symptomatic Subjects With Generalized Myasthenia Gravis
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in Symptomatic Subjects With Generalized Myasthenia Gravis
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Enrollment Status: Completed
Publish Date: July 06, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 4 Less Clinical Trials

30 Total Publications

Measuring the effect of rozanolixizumab using the Myasthenia Gravis Impairment Index: analyses from the randomized phase 3 MycarinG study.
Measuring the effect of rozanolixizumab using the Myasthenia Gravis Impairment Index: analyses from the randomized phase 3 MycarinG study.
Journal: Journal of neurology
Published: July 22, 2025
Similar Doctors
Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required

Indiana University Medical Center

545 Barnhill Dr, 
Indianapolis, IN 
 (1.1 miles away)
317-274-8800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Martin Farlow is a Neurologist practicing medicine in Indianapolis, Indiana. Dr. Farlow is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Alzheimer's Disease, Dementia, Gerstmann-Straussler-Scheinker Syndrome, and Frontotemporal Dementia. Dr. Farlow is currently accepting new patients.

Expertise in
29
conditions
Expertise in
29
conditions
Referral may be required

IU Health Methodist Hospital

1701 Senate Blvd, 
Indianapolis, IN 
 (0.1 miles away)
317-962-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Edward Dropcho is a Neurologist practicing medicine in Indianapolis, Indiana. Dr. Dropcho is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Glioblastoma, Gliomatosis Cerebri, and Astrocytoma. Dr. Dropcho is currently accepting new patients.

Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required

Office

250 N Shadeland Ave, 
Indianapolis, IN 
 (6.3 miles away)
317-948-5450
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Liana Apostolova is a Neurologist practicing medicine in Indianapolis, Indiana. Dr. Apostolova is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Alzheimer's Disease, Dementia, Primary Amyloidosis, and Developmental Dysphasia Familial. Dr. Apostolova is currently accepting new patients.

Frequently Asked Questions about Dr. Robert M. Pascuzzi

How do I make an appointment with Dr. Robert M. Pascuzzi?

You can book an appointment with Dr. Robert M. Pascuzzi by calling their office at 317-963-7000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Robert M. Pascuzzi a top-rated expert for Myasthenia Gravis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Robert M. Pascuzzi is classified as an Elite expert for Myasthenia Gravis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Robert M. Pascuzzi specialize in?

While Dr. Robert M. Pascuzzi is a Neurology, they have specific expertise in Myasthenia Gravis, Lambert-Eaton Syndrome, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Robert M. Pascuzzi participate in research or clinical trials?

Yes. Dr. Robert M. Pascuzzi has published 30 articles and abstracts on conditions like Myasthenia Gravis. You can view a list of Dr. Robert M. Pascuzzi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Robert M. Pascuzzi accept my insurance?

Dr. Robert M. Pascuzzi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 317-963-7000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pascuzzi's expertise for a condition
ConditionClose
View All 36 Advanced Conditions
View All 178 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile